John Fasig Iii, MD - Medicare Pathology in Brentwood, TN

John Fasig Iii, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Brentwood, Tennessee. He went to University Of Iowa, Rj & L Carver College Of Medicine and graduated in 2003 and has 21 years of diverse experience with area of expertise as Pathology. He is a member of the group practice Associated Pathologists Llc, Associated Pathologists Llc, Associated Pathologists Llc, Associated Pathologists Llc and his current practice location is 5301 Virginia Way, Suite 300, Brentwood, Tennessee. You can reach out to his office (for appointments etc.) via phone at (615) 221-4474.

John Fasig Iii is licensed to practice in Tennessee (license number 43243) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1104973080.

Contact Information

John Fasig Iii, MD
5301 Virginia Way, Suite 300,
Brentwood, TN 37027-7541
(615) 221-4474
(615) 234-3774



Physician's Profile

Full NameJohn Fasig Iii
GenderMale
SpecialityPathology
Experience21 Years
Location5301 Virginia Way, Brentwood, Tennessee
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • John Fasig Iii attended and graduated from University Of Iowa, Rj & L Carver College Of Medicine in 2003
  NPI Data:
  • NPI Number: 1104973080
  • Provider Enumeration Date: 01/04/2007
  • Last Update Date: 08/14/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 4587732862
  • Enrollment ID: I20081014000572

Medical Identifiers

Medical identifiers for John Fasig Iii such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1104973080NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 43243 (Tennessee)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Tristar Centennial Medical CenterNashville, TNHospital
Baptist Memorial HospitalMemphis, TNHospital
Baptist Memorial Hospital Golden Triangle IncColumbus, MSHospital
Greenview Regional HospitalBowling green, KYHospital
Poplar Bluff Regional Medical CenterPoplar bluff, MOHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Associated Pathologists Llc0648167544103
Associated Pathologists Llc0648167544103
Associated Pathologists Llc0648167544103
Associated Pathologists Llc0648167544103

News Archive

First Edition: February 14, 2012

Today's early morning highlights from the major news organizations include news on congressional package to payroll taxes and stop a Medicare payment cut and analysis of President Barack Obama's budget.

BMI not linked with either surgical complications or esophageal cancer patient survival

Researchers at Moffitt Cancer Center in Tampa, Fla., have found - contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) - that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

Infants born to women with Inflammatory Bowel Disease (IBD) are no more likely to develop congenital malformations than infants born to healthy mothers, according to a study presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.

New LNP compositions that improve systemic delivery of RNAi therapeutics discovered

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. John Fasig Iii allows following entities to bill medicare on his behalf.
Entity NameAssociated Pathologists Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003863580
PECOS PAC ID: 0648167544
Enrollment ID: O20040304000200

News Archive

First Edition: February 14, 2012

Today's early morning highlights from the major news organizations include news on congressional package to payroll taxes and stop a Medicare payment cut and analysis of President Barack Obama's budget.

BMI not linked with either surgical complications or esophageal cancer patient survival

Researchers at Moffitt Cancer Center in Tampa, Fla., have found - contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) - that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

Infants born to women with Inflammatory Bowel Disease (IBD) are no more likely to develop congenital malformations than infants born to healthy mothers, according to a study presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.

New LNP compositions that improve systemic delivery of RNAi therapeutics discovered

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John Fasig Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
John Fasig Iii, MD
5301 Virginia Way, Suite 300,
Brentwood, TN 37027-7541

Ph: (615) 221-4474
John Fasig Iii, MD
5301 Virginia Way, Suite 300,
Brentwood, TN 37027-7541

Ph: (615) 221-4474

News Archive

First Edition: February 14, 2012

Today's early morning highlights from the major news organizations include news on congressional package to payroll taxes and stop a Medicare payment cut and analysis of President Barack Obama's budget.

BMI not linked with either surgical complications or esophageal cancer patient survival

Researchers at Moffitt Cancer Center in Tampa, Fla., have found - contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) - that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

Infants born to women with Inflammatory Bowel Disease (IBD) are no more likely to develop congenital malformations than infants born to healthy mothers, according to a study presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.

New LNP compositions that improve systemic delivery of RNAi therapeutics discovered

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.

Read more News

› Verified 7 days ago


Pathology Doctors in Brentwood, TN

Kathy Bruner, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027
Phone: 615-221-4474    Fax: 615-234-3774
Kenneth S Piech, M.D.
Pathology
Medicare: Medicare Enrolled
Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027
Phone: 615-221-4474    Fax: 615-234-3774
Roy W. Kirchberg Jr., M.D.
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027
Phone: 615-221-4474    Fax: 615-234-3774
Dr. Lori D Emerson, MD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027
Phone: 615-695-4977    
Ben W Davis, M.D.
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 5301 Virginia Way Ste 300, Brentwood, TN 37027
Phone: 615-221-4474    Fax: 615-234-3774
Randall L Woodford, MD
Pathology
Medicare: Medicare Enrolled
Practice Location: 5301 Virginia Way, 300, Brentwood, TN 37027
Phone: 615-221-4474    Fax: 615-234-3774
Dr. Soheila Yadrandji, MD
Pathology
Medicare: Medicare Enrolled
Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027
Phone: 615-221-4474    Fax: 615-234-3774

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.